Overview / Abstract: |
Program Overview Pain is a significant public health problem, affecting more than 100 million adults in the US and causing significant reductions in patients’ quality of life. The use of narcotic medications for pain management has increased dramatically in the US over the past two decades. However, pain patients are often undertreated due to a variety of physician- and patient-related concerns and barriers. In addition, despite the pain-relieving properties of opioid medications, the potential for abuse remains a concern. In response to this apprehension about opioid misuse, overdose, abuse, and addiction, the Food and Drug Administration (FDA) developed the Risk Evaluation and Mitigation Strategy (REMS) to ensure that the benefits outweigh the risks for long-acting and extended-release opioid analgesics. The activity, Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS): Education for Healthcare Providers, incorporates the REMS blueprint into education that is designed to induce changes in knowledge, competence, and performance that will translate into improved quality of patient care and reduced pain for patients. At the conclusion of this activity, participants should be able to demonstrate the ability to: Describe components of an effective treatment plan, such as treatment goals, patient interactions, and collaboration with the healthcare team |
Expiration |
Dec 21, 2019 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
3.0 |
Accreditation |
ACCME, ANCC, ACPE, AANP |
Presenters / Authors / Faculty |
Lynn R. Webster, MD Vice President of Scientific Affairs Adjunct Assistant Clinical Professor Chief Executive Officer |
Activity Specialities / Related Topics |
Emergency Medicine, Family Medicine, Internal Medicine, Pain Management, Primary Care |
Sponsors / Supporters / Grant Providers |
This educational activity is supported by an independent educational grant from the Extended-Release/Long-Acting Opioid Analgesic REMS Program Companies. |
Keywords / Search Terms |
Relias LLC Opioid, REMS, prescription, analgesic, pain management Free CE CME |